NCT07004790

Brief Summary

This prospective observational study aims to determine whether specific parameters measured by transcranial Doppler ultrasound (TCD) can predict clinical outcomes in patients with acute ischemic stroke (AIS). The primary objective is to evaluate the association between middle cerebral artery (MCA) flow velocities and short-term neurological improvement. Secondary outcomes include the presence of collateral flow and flow patterns in relation to functional recovery measured by NIHSS and modified Rankin Scale (mRS) scores.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
13mo left

Started Aug 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 27, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 4, 2025

Completed
1.2 years until next milestone

Study Start

First participant enrolled

August 1, 2026

Expected
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2027

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2027

Last Updated

September 16, 2025

Status Verified

September 1, 2025

Enrollment Period

12 months

First QC Date

May 27, 2025

Last Update Submit

September 13, 2025

Conditions

Keywords

stroketranscranial dopplerPrognosisMiddle Cerebral ArteryCerebral HemodynamicsMexico

Outcome Measures

Primary Outcomes (1)

  • Change in NIHSS score from baseline to 72 hours

    Neurological status will be assessed using the National Institutes of Health Stroke Scale (NIHSS) at baseline (upon admission) and again at 72 hours. The primary objective is to evaluate the correlation between initial transcranial Doppler (TCD) measurements-specifically, mean flow velocity and pulsatility index in the middle cerebral artery-and the degree of clinical improvement or deterioration, as reflected by changes in NIHSS score. A greater reduction in NIHSS score indicates better neurological recovery. The NIH Stroke Scale (NIHSS) is a standardized, 15-item clinical assessment tool used to evaluate the severity of neurologic deficits in patients with acute stroke. The total NIHSS score ranges from 0 to 42, where: 0 = no stroke symptoms Higher scores indicate greater stroke severity and worse neurological outcomes The scale includes assessments of level of consciousness, gaze, visual fields, motor strength, limb ataxia, sensory function, language, and neglect.

    72 hours

Secondary Outcomes (2)

  • Presence of collateral circulation associated with ≥ 4-point NIHSS improvement

    7 days

  • Functional status at discharge (modified Rankin Scale)

    At hospital discharge (within 14 days of admission)

Study Arms (1)

Inpatient Stroke confirmed

OTHER

All participants diagnosed with acute ischemic stroke will undergo standard clinical evaluation and transcranial Doppler ultrasound within 24 hours of symptom onset. No interventions are assigned by the study. Clinical and hemodynamic data will be collected to assess prognostic associations with short-term outcomes. All patients are managed according to routine care protocols determined by the attending medical team.

Diagnostic Test: Transcranial Doppler Ultrasound

Interventions

A non-invasive bedside diagnostic procedure used to measure cerebral blood flow velocities and pulsatility index in intracranial arteries, primarily the middle cerebral artery (MCA). The test is performed within the first 24 hours of symptom onset using standard ultrasound equipment with a 2-MHz probe. The data collected is used solely for prognostic evaluation and does not influence treatment decisions.

Inpatient Stroke confirmed

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Clinical diagnosis of acute ischemic stroke
  • Onset of symptoms ≤ 24 hours before admission
  • Underwent or will undergo transcranial Doppler ultrasound within 24 hours of symptom onset
  • Able to provide informed consent or consent obtained from a legal representative

You may not qualify if:

  • Evidence of intracerebral hemorrhage on imaging
  • Inadequate temporal acoustic window for transcranial Doppler
  • Intubated or hemodynamically unstable prior to Doppler evaluation
  • Known diagnosis of neurodegenerative disease significantly affecting baseline neurological function (e.g., advanced dementia, Parkinson's disease)
  • Refusal to participate or withdrawal of consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Alexandrov AV, Sloan MA, Wong LK, Douville C, Razumovsky AY, Koroshetz WJ, Kaps M, Tegeler CH; American Society of Neuroimaging Practice Guidelines Committee. Practice standards for transcranial Doppler ultrasound: part I--test performance. J Neuroimaging. 2007 Jan;17(1):11-8. doi: 10.1111/j.1552-6569.2006.00088.x.

    PMID: 17238867BACKGROUND

MeSH Terms

Conditions

Stroke

Interventions

Ultrasonography, Doppler, Transcranial

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

EchoencephalographyNeuroradiographyNeuroimagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisRadiographyUltrasonographyUltrasonography, DopplerDiagnostic Techniques, NeurologicalInvestigative Techniques

Central Study Contacts

JOSE IVAN RODRIGUEZ DE MOLINA SERRANO, MD, MSc, Ph, Crit Care sp

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Participants with confirmed acute ischemic stroke will be enrolled consecutively and followed as a single cohort. All participants will undergo baseline clinical assessment and transcranial Doppler ultrasound within 24 hours of symptom onset. No grouping or randomization will be applied. The study will observe natural clinical progression and outcomes without intervention assignment.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Head of Research and Medical Education Clinica Mexico

Study Record Dates

First Submitted

May 27, 2025

First Posted

June 4, 2025

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

July 31, 2027

Study Completion (Estimated)

August 30, 2027

Last Updated

September 16, 2025

Record last verified: 2025-09